Showing results (401-410 of 4,698) with videos related to
Sort By:
Pageof 470
Seminars in Oncology|February 1, 1997
Antagonistic and agonistic effects of tamoxifen: significance in human cancerM A Gallo, D KaufmanSeminars in Oncology|February 1, 1997
Gynecologic oncology group trials in ovarian carcinomaR F OzolsSeminars in Oncology|February 1, 1997
Paclitaxel in head and neck and other cancers: future prospectsJ Aisner, H Cortés-FunesSeminars in Oncology|February 1, 1997
Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group studyW P McGuire, W J Hoskins, M F Brady, et al.Seminars in Oncology|February 1, 1997
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trialH G Meerpohl, A du Bois, H J Luck, et al.Seminars in Oncology|February 1, 1997
Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancerD W Fennelly, C Aghajanian, F Shapiro, et al.Seminars in Oncology|February 1, 1997
Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding studyW ten Bokkel Huinink, C Veenhof, M Huizing, et al.Seminars in Oncology|February 1, 1997
Taxane/platinum/anthracycline combination therapy in advanced epithelial ovarian cancerM Hill, V Macfarlane, J Moore, et al.Seminars in Oncology|February 1, 1997
The role of paclitaxel in the management of patients with carcinoma of the cervixT Thigpen, R Vance, T Khansur, et al.Seminars in Oncology|February 1, 1997
Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancerR Hitt, J Hornedo, R Colomer, et al.Pageof 470